Literature DB >> 10491196

Mechanisms and kinetics of procathepsin D activation.

S Wittlin1, J Rösel, F Hofmann, D R Stover.   

Abstract

In vitro, procathepsin D is activated to pseudocathepsin D by incubation at low pH. To investigate the mechanism of this activation, recombinant human procathepsin D and two mutants were generated in a baculovirus expression system. One mutant carried a point mutation within the catalytic domain, which resulted in a catalytically inactive enzyme form (D77A). The other carried a point mutation within the propeptide, which prevented activation by processing at the 'autoproteolysis-site' (L26P). Neither mutant is capable of processing itself to form pseudocathepsin D, and L26P is not able to process D77A. Despite the inability of L26P to cleave either its own or a wild-type prosequence, it did exhibit activity against a synthetic peptide substrate. The ability of intact precursor (zymogen) to cleave a peptide, but not a protein substrate, offers new insights into the mechanism of inhibition by the propeptide. Mature cathepsin D can process the inactive D77A mutant to the pseudoform, demonstrating that processed species are capable of cleaving zymogen molecules in an intermolecular interaction. In addition, kinetic studies provide evidence for a two-phase mechanism for the conversion of procathepsin D to pseudocathepsin D, one phase where the first molecules of pseudocathepsin D are formed at a low rate and a second phase where the process is autocatalytically accelerated by newly formed pseudocathepsin D molecules. Finally, with the help of the mutants L26P and D77A it was observed that at least two additional proteinase activities, found in conditioned media from insect cell culture, are capable of activating procathepsin D by cleaving it within the proregion. This observation suggests that there are likely to be multiple proteinases in the extracellular matrix that are capable of activating procathepsin D, thereby triggering the second autocatalytic phase. This may also be important for solid tumors, where the presence of cathepsin D has been correlated with tumor growth and invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491196     DOI: 10.1046/j.1432-1327.1999.00747.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Proteolytic Systems in Milk: Perspectives on the Evolutionary Function within the Mammary Gland and the Infant.

Authors:  David C Dallas; Niamh M Murray; Junai Gan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-16       Impact factor: 2.673

2.  The Role of DmCatD, a Cathepsin D-Like Peptidase, and Acid Phosphatase in the Process of Follicular Atresia in Dipetalogaster maxima (Hemiptera: Reduviidae), a Vector of Chagas' Disease.

Authors:  Jimena Leyria; Leonardo L Fruttero; Magalí Nazar; Lilián E Canavoso
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

3.  Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.

Authors:  Victoria J Butler; Wilian A Cortopassi; Andrea R Argouarch; Sam L Ivry; Charles S Craik; Matthew P Jacobson; Aimee W Kao
Journal:  J Mol Biol       Date:  2019-01-25       Impact factor: 5.469

4.  Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.

Authors:  Valérie Laurent-Matha; Danielle Derocq; Christine Prébois; Nobuhiko Katunuma; Emmanuelle Liaudet-Coopman
Journal:  J Biochem       Date:  2006-03       Impact factor: 3.387

5.  Procathepsin D and cancer: From molecular biology to clinical applications.

Authors:  Vaclav Vetvicka; Aruna Vashishta; Sujata Saraswat-Ohri; Jana Vetvickova
Journal:  World J Clin Oncol       Date:  2010-11-10

6.  A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration.

Authors:  J Tyynelä; I Sohar; D E Sleat; R M Gin; R J Donnelly; M Baumann; M Haltia; P Lobel
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

7.  Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation.

Authors:  Madanan Madathiparambil Gopalakrishnan; Hans-Wilhelm Grosch; Silvia Locatelli-Hoops; Norbert Werth; Eva Smolenová; Michael Nettersheim; Konrad Sandhoff; Andrej Hasilik
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.

Authors:  Daniel E Abbott; Naira V Margaryan; Jacqueline S Jeruss; Seema Khan; Virginia Kaklamani; David J Winchester; Nora Hansen; Alfred Rademaker; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2010-01-15       Impact factor: 4.742

9.  A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells.

Authors:  Sanna Partanen; Stephan Storch; Hans-Gerhard Löffler; Andrej Hasilik; Jaana Tyynelä; Thomas Braulke
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

10.  Proteolytic activation of human cathepsin A.

Authors:  Nilima Kolli; Scott C Garman
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.